Healthy Inc > Blog > pharmaceutical manufacturing Mumbai
Posted on:

What is Biperiden Hydrochloride used for?

In the pharmaceutical industry, Biperiden Hydrochloride tablets (typically 2 mg) are a potent synthetic anticholinergic agent used primarily for its effects on the central nervous system. As a pharmacist, I characterize Biperiden as a critical “corrective” medication, essential for restoring the balance between the dopaminergic and cholinergic systems in the brain.

Primary Clinical Uses

  • Parkinson’s Disease: Used as adjunctive therapy in all forms of Parkinsonism (postencephalitic, arteriosclerotic, or idiopathic). it is particularly effective in reducing muscle rigidity and tremors.

  • Extrapyramidal Symptoms (EPS): This is its most frequent modern application. It is used to control drug-induced movement disorders caused by antipsychotic medications (neuroleptics), such as acute dystonia, akathisia, and secondary Parkinsonism.

  • Nicotine Poisoning: Occasionally utilized in specific clinical settings as an antidote for nicotine poisoning due to its antagonistic effects on nicotinic receptors.

Mechanism of Action

Biperiden is a selective central nervous system anticholinergic. It works by competitively antagonizing acetylcholine at the muscarinic receptors. In the striatum of the brain, Parkinsonian symptoms occur when there is an imbalance—specifically, too little dopamine and too much cholinergic activity. Biperiden acts to dampen that excessive cholinergic signaling, thereby reducing involuntary muscle movements and stiffness.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Biperiden is a specialized CNS (Central Nervous System) molecule that fits into “niche” psychiatric and neurological portfolios:

  • Potency and Precision: Because Biperiden is highly potent at a low dose (2 mg), our manufacturing process involves high-shear granulation to ensure absolute content uniformity across every tablet in the batch.

  • Stability & Shelf Life: Biperiden Hydrochloride is generally stable, but we utilize Alu-PVC or Alu-Alu packaging to ensure the product maintains its chemical integrity when exported to varied climates, specifically targeting the CIS, Middle East, and Southeast Asian markets.

  • Global Demand: While not as high-volume as a generic antibiotic, Biperiden is a “mandatory” stock item for psychiatric hospitals and B2B distributors who handle neuroleptic medications, as it is the primary rescue medication for EPS.

  • Regulatory Support: As a WHO-GMP facility, we provide the necessary CTD Dossiers and stability data to facilitate the registration of this CNS agent in international markets, ensuring a reliable supply for specialized healthcare sectors.

Biperiden Tablets

Posted on:

What is the use of Azithromycin dispersible tablets?

In the pharmaceutical industry, Azithromycin Dispersible Tablets (typically 100 mg or 250 mg) are a specialized pediatric formulation of the macrolide antibiotic class. As a pharmacist, I view the dispersible format as a critical advancement in “patient-centric” medicine—ensuring that children receive the precise, potent dose of a broad-spectrum antibiotic without the struggle of swallowing large pills or the stability issues often found in liquid suspensions.

Primary Clinical Uses

  • Upper Respiratory Tract Infections (URTI): Highly effective for tonsillitis, pharyngitis, and acute sinusitis.

  • Lower Respiratory Tract Infections (LRTI): A first-line treatment for community-acquired pneumonia and acute bacterial exacerbations of bronchitis.

  • Acute Otitis Media: The primary choice for middle ear infections in children due to its high tissue penetration.

  • Skin and Soft Tissue Infections: Used for uncomplicated infections caused by Staphylococcus aureus or Streptococcus pyogenes.

Mechanism of Action

Azithromycin works by binding to the 50S ribosomal subunit of susceptible microorganisms. This action interferes with microbial protein synthesis by inhibiting the transpeptidation/translocation step.

What makes Azithromycin unique from a pharmacokinetic standpoint is its extensive tissue distribution. It concentrates within lysosomes and white blood cells (phagocytes), which then “transport” the drug directly to the site of infection. This results in high local concentrations and allows for a convenient once-daily dosing schedule.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, the dispersible tablet is a high-tech solution for global health:

  • Instant Disintegration: As a WHO-GMP standard, these tablets are formulated to disintegrate in less than 60 seconds in a teaspoon of water, forming a smooth suspension that is easy for infants and children to swallow.

  • Taste-Masking Excellence: Azithromycin API is notoriously bitter. Our formulation involves advanced taste-masking technology and fruit flavors (like strawberry or mango) to ensure pediatric compliance and prevent “spit-ups.”

  • Stability in Transit: Unlike liquid syrups which require bulky glass bottles and have shorter shelf lives once reconstituted, dispersible tablets are lightweight and highly stable. We utilize Alu-Alu blister packaging to protect the API from moisture and light, making it ideal for export to Zone IVb climates.

  • Global Market Demand: These tablets are essential for B2B distributors and international NGO tenders (like UNICEF) catering to pediatric health in Africa, Southeast Asia, and the Middle East.

Azithromycin Dispersible Tablet

Posted on:

What is Azatioprine used to treat?

In the pharmaceutical industry, Azathioprine tablets (commonly 50 mg) are classified as a potent immunosuppressant and a prodrug of 6-mercaptopurine. As a pharmacist, I view Azathioprine as a critical “steroid-sparing” agent, allowing clinicians to reduce long-term corticosteroid use while maintaining control over the immune system.

Primary Clinical Uses

  • Organ Transplant Rejection: Used as a mainstay adjunctive therapy to prevent the rejection of kidney, heart, and liver transplants, typically in combination with other immunosuppressants.

  • Rheumatoid Arthritis (RA): Indicated for patients with severe, active RA who have not responded to conventional first-line Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

  • Inflammatory Bowel Disease (IBD): Widely used to maintain remission in patients with Crohn’s Disease and Ulcerative Colitis.

  • Autoimmune Disorders: Effective in treating Systemic Lupus Erythematosus (SLE), autoimmune hepatitis, and Myasthenia Gravis.

Mechanism of Action

Azathioprine is a purine antimetabolite. Once ingested, it is rapidly converted into 6-mercaptopurine (6-MP). It acts by interfering with DNA and RNA synthesis within rapidly dividing cells, particularly T-lymphocytes and B-lymphocytes. By inhibiting the proliferation of these immune cells, Azathioprine suppresses the body’s autoimmune attack or the rejection response against a donor organ.

Technical Note: The metabolism of Azathioprine depends on the enzyme TPMT (Thiopurine Methyltransferase). As a pharmacist, I always emphasize that patients should ideally be screened for TPMT activity before starting therapy to avoid severe bone marrow toxicity.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Azathioprine is a high-sensitivity molecule requiring rigorous quality standards:

  • Cytotoxic Handling: Azathioprine is a potent substance. In our manufacturing processes, we adhere to strict containment protocols and WHO-GMP standards to prevent cross-contamination and ensure worker safety.

  • Stability & Coating: The tablets are typically film-coated to protect the active ingredient from light and to prevent dust exposure during handling. We ensure the coating provides a robust barrier for long-term stability in export conditions.

  • Global Export Niche: Azathioprine is a vital product for B2B marketplaces and hospital supply chains catering to oncology and transplant centers in the CIS, Middle East, and Africa.

  • Documentation: We provide full CTD/eCTD Dossiers, including stability data for Zone IVb, to facilitate registration in international markets where chronic disease management is expanding.

Azathioprine Tablets

Posted on:

What is the use of artesunate and amodiaquine tablets?

In the pharmaceutical industry, the combination of Artesunate and Amodiaquine (AS+AQ) is a cornerstone of Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a vital public health tool, specifically engineered to combat Plasmodium falciparum malaria by providing a “one-two punch” that eliminates parasites at different stages of their life cycle.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated as a first-line therapy for acute, uncomplicated malaria infections, especially in regions with high chloroquine resistance.

  • Pediatric and Adult Populations: Available in specific weight-based strengths (e.g., 25/67.5 mg, 50/135 mg, and 100/270 mg) to ensure precise dosing and reduce the risk of sub-therapeutic treatment.

  • Rapid Parasite Clearance: Used to achieve high cure rates (typically >95%) and to prevent the progression of the disease into severe, life-threatening malaria.

Mechanism of Action

This FDC utilizes two distinct chemical classes to ensure maximum parasiticidal effect:

Artesunate (Artemisinin Derivative): It acts rapidly by reacting with the iron in the parasite’s heme to generate reactive free radicals. These radicals cause widespread damage to the parasite’s cell membranes and essential proteins, resulting in a rapid “knockdown” of the parasite load.

Amodiaquine (4-Aminoquinoline): It acts as a long-acting blood schizontocide. It interferes with the parasite’s ability to detoxify heme (converting it into non-toxic hemozoin). The resulting accumulation of toxic free heme leads to the death of any parasites that survived the initial Artesunate burst.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+AQ is a technically sensitive product that demands high-tier quality control:

  • Bilayer Tablet Technology: Because Artesunate is highly sensitive to moisture and can interact with the Amodiaquine salt, we often utilize bilayer compression. This physical separation within a single tablet enhances the stability and shelf-life of the product.

  • Hygroscopic Protection: Artesunate is moisture-labile. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to provide a superior moisture barrier, ensuring the tablets remain stable in Zone IVb (hot and humid) climates.

  • Global Health Compliance: This combination is a staple for international health tenders (e.g., Global Fund, USAID). Our Mumbai-based facility is optimized for high-capacity production with full CTD/eCTD Dossier support for rapid international registration.

  • Safety Monitoring: We adhere to strict API standards to minimize the risk of rare adverse effects like neutropenia or hepatotoxicity, ensuring the product is as safe as it is effective.

Artesunate Amodiaquine Tablets

Posted on:

What is the use of artesunate mefloquine?

In the pharmaceutical industry, the combination of Artesunate and Mefloquine (ASMQ) is a high-efficacy Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a critical therapeutic option for regions with multi-drug resistant malaria, as it pairs the fastest-acting antimalarial with one of the longest-lasting ones.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Primarily indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum.

  • Multi-Drug Resistant Regions: It is a first-line therapy in areas where parasites have developed resistance to other ACTs (such as Southeast Asia and parts of South America).

  • Prevention of Transmission: By rapidly clearing the parasite load, it reduces the reservoir of infection within a community, helping to curb the spread of malaria.

Mechanism of Action

This combination offers a “synergistic blockade” against the malaria parasite:

Artesunate (Fast-Acting): Quickly reduces the parasite biomass by generating reactive free radicals that disrupt the parasite’s cell membranes and essential proteins.

Mefloquine (Long-Acting): A quinoline methanol derivative that acts by interfering with the parasite’s ability to detoxify heme (the byproduct of hemoglobin digestion). Its long half-life ensures that any remaining parasites are eliminated over several weeks, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, ASMQ is a technically sophisticated product that demands high quality standards:

  • Stability & Hygroscopicity: Artesunate is highly sensitive to moisture. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and strictly controlled, low-humidity production environments to prevent degradation during export to tropical Zone IVb climates.

  • Side Effect Mitigation: Mefloquine is sometimes associated with neurological side effects. By formulating it as an FDC with Artesunate, we ensure precise dosing which helps maintain the therapeutic window and improves the safety profile compared to loosely combined monotherapies.

  • Fixed-Dose Combination (FDC) Technology: We specialize in the complex formulation required to keep both APIs stable within a single tablet, ensuring consistent dissolution and bioavailability for both components.

  • Global Export Hub: Operating from Mumbai, we provide the CTD/eCTD Dossiers and stability data required for registration in international markets, supporting B2B partners and government tenders in malaria-endemic regions.

Artesunate Mefloquine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500 mg/25 mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

Artesunate Sulphadoxine Pyrimethamine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

  • Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500mg/25mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

 

Posted on:

What is ascorbic acid vitamin C tablets used for?

In the pharmaceutical industry, Ascorbic Acid (Vitamin C) tablets (commonly available in 100 mg, 500 mg, and 1000 mg) are the most widely recognized essential water-soluble vitamins. As a pharmacist, I view Vitamin C not just as a supplement, but as a vital cofactor for collagen synthesis and a primary biological antioxidant that protects cellular components from oxidative stress.

Primary Clinical Uses

  • Treatment of Scurvy: The definitive treatment for Vitamin C deficiency, characterized by capillary fragility, bleeding gums, and impaired wound healing.

  • Immune System Enhancement: Used to support both innate and adaptive immune functions. It stimulates the production and function of white blood cells (leukocytes) and acts as a barrier against pathogens.

  • Iron Absorption: Frequently co-prescribed with iron supplements to treat anemia, as Vitamin C significantly enhances the absorption of non-heme iron in the gastrointestinal tract.

  • Supportive Therapy: Used to promote wound healing post-surgery, treat pressure sores, and manage chronic infections where oxidative stress is high.

Mechanism of Action

Ascorbic Acid acts as an electron donor for eight different enzymes. Its most critical role is in collagen hydroxylation, where it stabilizes the triple helix of collagen fibers, providing structural integrity to skin, blood vessels, and bones. As a potent antioxidant, it neutralizes reactive oxygen species (ROS), thereby preventing damage to DNA, proteins, and lipids.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Vitamin C is a high-volume product that requires specialized environmental controls:

  • Oxidation Control: Ascorbic Acid is highly sensitive to light, heat, and moisture, which causes it to turn yellow or brown. As a WHO-GMP manufacturer, we utilize strictly controlled RH (Relative Humidity) environments and opaque packaging to prevent degradation.

  • Chewable & Effervescent Varieties: To improve patient compliance, we focus on chewable tablets with advanced taste-masking for its natural acidity, as well as effervescent tablets for rapid absorption and better “mouthfeel.”

  • Global Export Staple: Vitamin C is a consistent top-seller in B2B marketplaces and international tenders. Our Mumbai-based facility provides customized strengths and packaging (strip/blister/bulk bottles) for the African, CIS, and Southeast Asian markets.

  • Quality Standards: We ensure all batches comply with BP/USP/IP monographs, specifically testing for “Related Substances” and “Assay” to guarantee the 24-month shelf life required for international shipping.

Ascorbic Acid Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Add to cart